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of drug resistance. However, knowledge of strain genotype 
is no less clinically and epidemiologically relevant. A super-
spreading strain might be marked with other pathobiologi-
cally important features. In the case presented here (indeed 
emerging and MDR), the NGS-based in silico spoligotyping 
would confuse the MDR/extensively drug resistant SIT266 
with “less dangerous” SIT264. To be precise, the revealed 
discrepancy is not inherent to the NGS technology itself. Al-
though the general limitation of the use of short sequencing 
reads to infer repetitive genome regions is known, it did not 
pose a problem in our study. However, both bioinformatics 
tools predicted the spoligoprofile solely from the presence or 
absence of spacer sequences and did not take into account 
a “hiding” effect exerted by a putative IS6110 insertion on 
adjacent spacer under classical spoligotyping.
In conclusion, we suggest that an accurate NGS-
based prediction requires an integrative approach to all 
relevant information obtained by in silico analysis of a 
given genome locus. In particular, not only presence of 
CRISPR spacers but also presence and location of poten-
tially interfering IS6110 insertion(s) should be considered 
for correct NGS-based assignment to internationally rec-
ognized spoligotypes.
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To the Editor: Accumulating evidence indicates that 
dromedaries (Camelus dromedarius) are a reservoir for 
zoonotic transmission of Middle East respiratory syndrome 
coronavirus (MERS-CoV). Although numerous studies 
have looked at other livestock in the Middle East region, 
evidence for MERS-CoV infection has only been found 
in dromedaries (1). Extensive and continuous circulation 
of MERS-CoV occurs in the Al Shahaniya region of Qa-
tar, most likely because of the presence of an international 
camel racing track and numerous barns holding camels 
(2,3). In April 2015, we investigated the MERS-CoV infec-
tion status of 15 healthy alpacas (Vicugna pacos) in a herd 
of 20 animals and 10 healthy dromedaries in a herd of 25 
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animals at a farm in this region (online Technical Appendix, 
http://wwwnc.cdc.gov/EID/article/22/6/15-2113-Techapp1.pdf). 
The herds were located at a distance of ≈200 m from 
each other within the barn complex and were cared for by 
the same animal workers, who lived in a common house 
between the herds at the complex. Both the alpacas and 
camels were kept as hobby animals. 
Serum samples were collected from all 25 animals. 
Nasal swabs were collected from all camels, whereas nasal, 
rectal, and oral swab specimens were collected only from a 
subset of the alpacas (online Technical Appendix) because 
of logistical constraints. The serum samples were tested 
for IgG antibodies reactive with the S1 antigens of MERS-
CoV and severe acute respiratory syndrome coronavirus 
(SARS-CoV), and titers were calculated as described previ-
ously (4,5). MERS-CoV reactivity was confirmed by using 
a 90% plaque-reduction neutralization test (PRNT90) (3). 
Swab specimens were analyzed for MERS-CoV RNA by 
a screening PCR targeting the upE gene (6). MERS-CoV–
specific antibodies were detected in all alpacas and all but 1 
camel by protein microarray; reciprocal titers ranged from 
49 to 773 for the alpacas and were >1,280 for the camels 
(Figure, panel A). PRNT90 testing confirmed the presence 
of MERS-CoV–specific antibodies; reciprocal neutralizing 
titers ranged from 80 to 320 for the alpacas and from 80 to 
>2560 for 9 camels (Figure, panel B). All swab specimens 
were negative by PCR (online Technical Appendix). None 
of the serum samples were reactive to SARS-CoV S1. The 
microarray was also conducted for bovine CoV and human 
CoV-229E antigens, which were used as a proxy for the 
serologically closely related dromedary betacoronavirus-1 
HKU23 and 229E-related camelid alphacoronaviruses, re-
spectively (7). Positive binding was detected for both anti-
gens in alpaca and dromedary (data not shown). 
Our observations prove the susceptibility of alpacas 
for natural MERS-CoV infection and lay the foundation 
for future studies to determine the potential of alpacas as 
another livestock reservoir for MERS-CoV. The alpacas in 
this study were the only alpacas in Qatar at the time and 
were located in a region where MERS-CoV is endemic. In 
a previous study, by using the same microarray technol-
ogy, we found no evidence for MERS-CoV infection in al-
pacas from regions where MERS-CoV is not endemic (4). 
Although a study by Eckerle et al. demonstrated the po-
tential of MERS-CoV to infect alpaca kidney cells in vitro 
(8) and alignment of mammalian DPP4 indicate that the 14 
residues interacting with the MERS-CoV receptor binding 
domain of alpaca DPP4 are identical to that of dromedary 
DPP4 (online Technical Appendix), the in vivo susceptibil-
ity of alpacas remained to be determined. 
The observed natural susceptibility of alpacas to 
MERS-CoV infection potentiates a broadening of the geo-
graphic range of MERS-CoV circulation to areas with large 
populations of alpacas. Alpacas are New World camelids, 
and the worldwide population of alpacas is estimated at 
3 million animals, with ≈94% living in the high Andean 
regions of South America (Peru, Bolivia, Chile and Ar-
gentina), of which most are in Peru (constituting ≈88% 
of the world alpaca population) (http://lib.icimod.org/ 
record/23682). Alpacas are increasingly being kept outside 
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Figure. Column scatterplots of MERS-CoV reactivity of serum samples from alpaca (n = 15) and dromedaries (n = 10) in the Al 
Shahaniya region of Qatar, April 2015. A) Plot of alpaca and dromedary serum titers of antibodies specific for S1 antigens of 2 
coronaviruses as determined by protein microarray. Titers were defined as the interpolated serum concentration that provoked a 
response half-way on a concentration-response curve between the minimum and maximum signal and were calculated from the 
inflection point of a 4-step dilution series (1:20 to 1:1,280) as described previously (5). B) Plot of alpaca and dromedary serum titers 
of MERS-CoV neutralizing antibodies as determined by PRNT90. The highest serum dilution neutralizing 90% of plaque formation 
is depicted. For both panels, solid lines indicate median, and dotted lines indicate detection limit. MERS, Middle East respiratory 
syndrome; CoV, coronavirus; PRNT90, 90% plaque-reduction neutralization test; SARS, severe acute respiratory syndrome.
South America, mainly for their fleece, with estimated 
numbers in 2014 reaching 230,000 in the United States 
(http://lib.icimod.org/record/23682), 35,000 in the United 
Kingdom (http://www.bas-uk.com), and 150,000 in Austra-
lia (http://www.alpaca.asn.au). Although MERS-CoV has 
not been found in camelids other than dromedaries outside 
the Arabian Peninsula so far (9), our observations raise the 
question of whether other camelids could become infected 
if MERS-CoV were introduced to regions with large popu-
lations of alpacas and possibly other closely related cam-
elids of the genera Lama, Vicugna, and Camelus.
Because the date of infection of the alpacas and cam-
els in this study is not known, we cannot speculate on the 
level of susceptibility of alpacas versus dromedaries based 
on the observed differences in antibody titers, which were 
lower in alpacas. It remains to be determined whether al-
pacas, in parallel with dromedaries, will actually shed 
MERS-CoV and are capable of independent maintenance 
of the virus in their population. Differences in susceptibili-
ty to viral pathogens between New and Old World camelids 
have been observed before (10). Therefore, understanding 
the risk requires further assessment of the reservoir compe-
tence of alpacas for MERS-CoV (e.g., through experimen-
tal infections) and an assessment of MERS-CoV–related 
viruses present in alpacas and other camelids in different 
parts of the world.
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To the Editor: Cryptococcus gattii is a fungal pathogen 
that is emerging in the Pacific Northwest of North America. 
In Nova Scotia, Canada, previously not recognized as a C. 
gattii–endemic area, a variant strain similar to VGIIb caused 
cryptococcosis with nasopulmonary, lymph node and cen-
tral nervous system involvement in a free-ranging, yearling 
white-tailed deer (Odocoileus virginianus). The deer was 
found in the village of Greenwood (latitude 44.9717246; 
longitude −64.9341295) on July 14, 2014. The deer ex-
hibited behavioral and neurologic abnormalities, including 
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